FDA National Drug Codes
Searching…
FDA National Drug Codes
Searching…
FDA National Drug Codes
Browse every product in the FDA NDC Directory below, or search by NDC, brand, generic, manufacturer or HCPCS code. Each product has its own page with package NDCs in 11-digit billing format.
10,781 products (finished products)
| Product | Strength | Form · route | Labeler | Application | Product NDC | Package NDCs (11-digit) | HCPCS |
|---|---|---|---|---|---|---|---|
| Cystagoncysteamine bitartrate | Cysteamine bitartrate 150 mg/1 | CapsuleOral | Mylan Pharmaceuticals Inc. | NDA | 0378-9045 | 00378-9045-05 | — |
| Cystarancysteamine hydrochloride | Cysteamine hydrochloride 6.5 mg/mL | SolutionOphthalmic | Leadiant Biosciences, Inc. | NDA | 54482-020 | 54482-0020-02 | — |
| Cystarancysteamine hydrochloride | Cysteamine hydrochloride 6.5 mg/mL | SolutionOphthalmic | Leadiant Biosciences, Inc. | NDA | 54482-035 | 54482-0035-02 | — |
| Cysteine Hydrochloride | Cysteine hydrochloride 34.5 mg/mL |
| InjectionIntravenous |
| Baxter Healthcare Corporation |
| NDA |
| 0338-9645 |
| 00338-9645-01 |
| — |
| Cystexmethenamine, sodium salicylate | Methenamine 162 mg/1; Sodium salicylate 162.5 mg/1 | TabletOral | Clarion Brands, LLC | Unapproved drug (other) | 69693-513 | 69693-0513-2469693-0513-48 | — |
|---|
| Cystexmethenamine, sodium salicylate | Methenamine 162 mg/1; Sodium salicylate 162.5 mg/1 | TabletOral | Clarion Brands, LLC | OTC monograph drug | 69693-518 | 69693-0518-2469693-0518-48 | — |
|---|
| Cystex Max Strength UTI Pain Relief | Phenazopyridine hydrochloride 99.5 mg/99.5mg | TabletOral | Clarion Brands LLC | OTC monograph drug | 69693-519 | 69693-0519-24 | — |
|---|
| Cystex Max UTI Pain Reliefphenazopyridine hydrochloride | Phenazopyridine hydrochloride 99.5 mg/1 | TabletOral | Clarion Brands, LLC | OTC monograph drug | 69693-514 | 69693-0514-24 | — |
|---|
| Cystex Plusmethenamine, sodium salicylate | Methenamine 162 mg/1; Sodium salicylate 162.5 mg/1 | TabletOral | Clarion Brands, LLC | Unapproved drug (other) | 69693-512 | 69693-0512-2069693-0512-2469693-0512-40+1 more | — |
|---|
| Cystex PMacetaminophen, diphenhydramine hcl | Acetaminophen 500 mg/1; Diphenhydramine hydrochloride 25 mg/1 | TabletOral | Clarion Brands, LLC | OTC monograph drug | 69693-417 | 69693-0417-1069693-0417-20 | — |
|---|
| Cysto-Conray IIiothalamate meglumine | Iothalamate meglumine 172 mg/mL | InjectionUreteral | Liebel-Flarsheim Company LLC | NDA | 0019-0862 | 00019-0862-50 | — |
|---|
| Cystoforcesarsaparilla, solidago virgaurea, uva ursi, apis mellifica, arsenicum album, cantharis, hepar sulphuris calcareum | Smilax ornata root 3 [hp_X]/mL + 6 more ingredients | LiquidOral | BioActive Nutritional, Inc. | Unapproved homeopathic | 43857-0170 | 43857-0170-01 | — |
|---|
| Cystoges HPberberis vulgaris root bark, lytta vesicatoria, clematis recta flowering top, canis lupus familiaris milk, lycopodium clavatum spore, pulsatilla vulgaris, sarsaparilla, sepia officinalis juice, delphinium staphysagria seed | Berberis vulgaris root bark 30 [hp_X]/mL + 8 more ingredients | LiquidOral | Natural Creations, Inc. | Unapproved homeopathic | 43406-0015 | 43406-0015-01 | — |
|---|
| Cystoges HPberberis vulgaris, cantharis, clematis erecta, lac caninum, lycopodium clavatum, pulsatilla (vulgaris), sarsaparilla, sepia, staphysagria | Lytta vesicatoria 30 [hp_X]/mL + 8 more ingredients | LiquidOral | BioActive Nutritional, Inc. | Unapproved homeopathic | 43857-0064 | 43857-0064-01 | — |
|---|
| Cystografindiatrizoate meglumine | Diatrizoate meglumine 300 mg/mL | Injection, SolutionIntravenous | BRACCO DIAGNOSTICS INC | NDA | 0270-0149 | 00270-0149-5700270-0149-60 | — |
|---|
| Cystografin Dilutediatrizoate meglumine | Diatrizoate meglumine 180 mg/mL | Injection, SolutionIntravesical | BRACCO DIAGNOSTICS INC | NDA | 0270-1410 | 00270-1410-30 | — |
|---|
| Cysviewhexaminolevulinate hydrochloride | — | Kit | Photocure Inc. | NDA | 10511-3001 | 10511-3001-02 | — |
|---|
| Cytaluxpafolacianine injection | Pafolacianine sodium 3.2 mg/1.6mL | InjectionIntravenous | On Target Laboratories, Inc. | NDA | 81052-138 | 81052-0138-10 | — |
|---|
| cytarabine | Cytarabine 100 mg/mL | Injection, SolutionIntrathecal, Intravenous, Subcutaneous | Sagent Pharmaceuticals | ANDA | 25021-223 | 25021-0223-20 | — |
|---|
| cytarabine | Cytarabine 20 mg/mL | Injection, SolutionIntrathecal, Intravenous, Subcutaneous | Sagent Pharmaceuticals | ANDA | 25021-229 | 25021-0229-05 | — |
|---|
| Cytarabine | Cytarabine 100 mg/mL | Injection, SolutionIntrathecal, Intravenous, Subcutaneous | Hospira, Inc. | ANDA | 61703-155 | 61703-0155-01 | — |
|---|
| Cytarabine | Cytarabine 20 mg/mL | Injection, SolutionIntravenous | Hospira, Inc. | ANDA | 61703-303 | 61703-0303-46 | — |
|---|
| Cytarabine | Cytarabine 20 mg/mL | Injection, SolutionIntravenous, Subcutaneous | Hospira, Inc. | ANDA | 61703-304 | 61703-0304-36 | — |
|---|
| Cytarabine | Cytarabine 20 mg/mL | Injection, SolutionIntrathecal, Intravenous, Subcutaneous | Hospira, Inc. | ANDA | 61703-305 | 61703-0305-38 | — |
|---|
| Cytarabine | Cytarabine 100 mg/mL | Injection, SolutionIntrathecal, Intravenous, Subcutaneous | Hospira, Inc. | ANDA | 61703-319 | 61703-0319-22 | — |
|---|
| Cytarabine | Cytarabine 100 mg/mL | Injection, SolutionIntrathecal, Intravenous, Subcutaneous | Fresenius Kabi USA, LLC | ANDA | 63323-120 | 63323-0120-20 | — |
|---|
| Cytarabine | Cytarabine 100 mg/mL | Injection, SolutionIntrathecal, Intravenous, Subcutaneous | Gland Pharma Limited | ANDA | 68083-337 | 68083-0337-01 | — |
|---|
| Cytarabine | Cytarabine 20 mg/mL | Injection, SolutionIntrathecal, Intravenous, Subcutaneous | Gland Pharma Limited | ANDA | 68083-343 | 68083-0343-05 | — |
|---|
| Cytarabine | Cytarabine 20 mg/mL | Injection, SolutionIntrathecal, Intravenous, Subcutaneous | Meitheal Pharmaceuticals Inc. | ANDA | 71288-108 | 71288-0108-06 | — |
|---|
| Cytarabine | Cytarabine 2 g/20mL | Injection, SolutionIntrathecal, Intravenous, Subcutaneous | Meitheal Pharmaceuticals Inc. | ANDA | 71288-109 | 71288-0109-20 | — |
|---|
| Cytarabine | Cytarabine 20 mg/mL | Injection, SolutionIntravenous, Subcutaneous | Meitheal Pharmaceuticals Inc. | ANDA | 71288-168 | 71288-0168-50 | — |
|---|
| Cytarabine | Cytarabine 20 mg/mL | Injection, SolutionIntravenous, Subcutaneous | Meitheal Pharmaceuticals Inc. | ANDA | 71288-169 | 71288-0169-25 | — |
|---|
| Cyto Homocytomegalovirus nosode | Human herpesvirus 5 18 [hp_X]/mL | LiquidOral | Deseret Biologicals, Inc | Unapproved homeopathic | 43742-1807 | 43742-1807-01 | — |
|---|
| Cytogamhuman cytomegalovirus immune globulin | Human cytomegalovirus immune globulin 2500 mg/50mL | LiquidIntravenous | Kamada Ltd. | BLA | 49591-532 | 49591-0532-51 | — |
|---|
| Cytomelliothyronine sodium | Liothyronine sodium 5 ug/1 | TabletOral | Pfizer Laboratories Div Pfizer Inc | NDA | 60793-115 | 60793-0115-01 | — |
|---|
| Cytomelliothyronine sodium | Liothyronine sodium 25 ug/1 | TabletOral | Pfizer Laboratories Div Pfizer Inc | NDA | 60793-116 | 60793-0116-01 | — |
|---|
| Cytomelliothyronine sodium | Liothyronine sodium 50 ug/1 | TabletOral | Pfizer Laboratories Div Pfizer Inc | NDA | 60793-117 | 60793-0117-01 | — |
|---|
| Cytotecmisoprostol | Misoprostol 100 ug/1 | TabletOral | Pfizer Laboratories Div Pfizer Inc | NDA | 0025-1451 | 00025-1451-60 | — |
|---|
| Cytotecmisoprostol | Misoprostol 200 ug/1 | TabletOral | Pfizer Laboratories Div Pfizer Inc | NDA | 0025-1461 | 00025-1461-3100025-1461-60 | — |
|---|
| Cyyzrose Antifungal Nailundecylenic acid 25% antifungal nail | Undecylenic acid 25 g/100mL | LiquidTopical | Jiangxi Yudexi Pharmaceutical Co., LTD | OTC monograph drug | 85248-222 | 85248-0222-0185248-0222-0285248-0222-03 | — |
|---|
| Cyzone All Black Desodorante Antitranspirante Roll Onaluminum sesquichlorohydrate | Aluminum sesquichlorohydrate 132.8 mg/g | EmulsionTopical | BEL STAR SA | OTC monograph drug | 14141-461 | 14141-0461-01 | — |
|---|
| Cyzone Cy Play Creamy Lip Balm Hidratante En Barra Para Labios 24H Fps 12 Berry Creamyoctinoxate, zinc oxide | Zinc oxide 39.2 mg/g; Octinoxate 25 mg/g | StickTopical | BEL STAR S A | OTC monograph drug | 14141-348 | 14141-0348-01 | — |
|---|
| Cyzone Cy Play Creamy Lip Balm Hidratante En Barra Para Labios 24H Fps 12 Cherry Creamyoctinoxate, zinc oxide | Zinc oxide 39.2 mg/g; Octinoxate 25 mg/g | StickTopical | BEL STAR S A | OTC monograph drug | 14141-349 | 14141-0349-01 | — |
|---|
| Cyzone Cy Play Creamy Lip Balm Hidratante En Barra Para Labios 24H Fps 12 Coral Creamyoctinoxate, zinc oxide | Zinc oxide 39.2 mg/g; Octinoxate 25 mg/g | StickTopical | BEL STAR S A | OTC monograph drug | 14141-309 | 14141-0309-01 | — |
|---|
| Cyzone Cy Play Creamy Lip Balm Hidratante En Barra Para Labios 24H Fps 12 Fuchsia Creamyoctinoxate, zinc oxide | Octinoxate 25 mg/g; Zinc oxide 39.2 mg/g | StickTopical | BEL STAR S A | OTC monograph drug | 14141-306 | 14141-0306-01 | — |
|---|
| Cyzone Cy Play Creamy Lip Balm Hidratante En Barra Para Labios 24H Fps 12 Nude Creamyoctinoxate, zinc oxide | Zinc oxide 39.2 mg/g; Octinoxate 25 mg/g | StickTopical | BEL STAR S A | OTC monograph drug | 14141-308 | 14141-0308-01 | — |
|---|
| Cyzone Cy Play Creamy Lip Balm Hidratante En Barra Para Labios 24H Fps 12 Pink Creamyoctinoxate, zinc oxide | Zinc oxide 39.2 mg/g; Octinoxate 25 mg/g | StickTopical | BEL STAR S A | OTC monograph drug | 14141-307 | 14141-0307-01 | — |
|---|
| Cyzone Nitro Air Desodorante Antitranspirante Roll Onaluminum sesquichlorohydrate | Aluminum sesquichlorohydrate 132.8 mg/g | EmulsionTopical | BEL STAR SA | OTC monograph drug | 14141-462 | 14141-0462-01 | — |
|---|
| Cyzone Nitro Desodorante Antitranspirante Roll Onaluminum sesquichlorohydrate | Aluminum sesquichlorohydrate 132.8 mg/g | EmulsionTopical | BEL STAR SA | OTC monograph drug | 14141-460 | 14141-0460-01 | — |
|---|
| Cyzone Studio Look Base De Alta Cobertura Y Larga Duracion Fps 20 Almendra 230-Noctinoxate, zinc oxide | Octinoxate 40 mg/g; Zinc oxide 24 mg/g | EmulsionTopical | BEL STAR S A | OTC monograph drug | 14141-030 | 14141-0030-01 | — |
|---|